Altavita D3 offers a choice of 1 x 50,000 IU soft capsule or 2 x Altavita 25,000 IU soft capsules for the treatment of Vitamin D deficiency (taken weekly for 6-8 weeks)*. 3-5
50,000 IU soft capsule
1
1
1 soft capsule per week for 6-8 weeks
Altavita 50,000 iu soft capsules is licensed for the treatment of vitamin d deficiency.
The recommended dose is 1 x Altavita 50,000 iu soft capsules per week for 6-8 weeks
25,000 IU soft capsule
1
1
2 capsules per week for 6 – 8 weeks
Altavita 25,000 iu soft capsules is licensed for the treatment of vitamin d deficiency.
The recommended dose is 2 x Altavita 25,000 iu soft capsules per week for 6 – 8 weeks
25,000 IU oral solution
1
1
2 x 1ml Oral Solution per week for 6-8 weeks
Altavita 25,000 iu oral solution is licensed for the treatment of vitamin d deficiency.
The recommended dose is 2 x Altavita 25,000 iu oral solutions per week for 6 – 8 weeks
This is the recommended dosage for treatment of vitamin D deficiency in adults. Altavita 25,000 iu soft capsules and 25,000 iu oral solution are also licensed for the prevention of vitamin D deficiency for further information click here.
Altavita 50,000 iu is not licensed for use in Children
For the Royal Osteoporosis Society Vitamin D Guidelines click here
FRAX Tool
Dose Cards
Patient Information Leaflet
References
- Consilient Health Ltd, Altavita® D3 1,000 IU soft capsules, SPC – available on medicines.ie
- Consilient Health Ltd, Altavita® D3 7,000 IU soft capsules, SPC– available on medicines.ie
- Consilient Health Ltd, Altavita® D3 25,000 IU soft capsules, SPC – available on medicines.ie
- Consilient Health Ltd, Altavita® D3 25,000 IU oral solution, SPC – available on medicines.ie
- Consilient Health Ltd, Altavita® D3 50,000 IU soft capsules, SPC – available on medicines.ie
- Royal Osteoporosis Society , Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management, December 2018, https://strwebprdmedia.blob.core.windows.net/media/ef2ideu2/ros-vitamin-d-and-bone-health-in-adults-february-2020.pdf, Accessed 06/05/2022
If you have a medical query about a Consilient Health medicine, please contact Consilient Health at drugsafety@consilienthealth.com or +353 (0)1 2057766. For all other queries, please contact our Irish office at Tel: +353 (0)1 2057760, Fax: +353 (0)1 2698919 or irishoffice@consilienthealth.com
Copyright ©2015 Consilient Health Ltd. All rights reserved. The information on this website is intended for healthcare professionals registered in the Republic of Ireland only.
IE-ALT-357(1) Date of Preparation: July 2023